Abstract
Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global Bacteriophage market size is projected to grow from US$ 51.2 million in 2024 to US$ 153 million in 2030; it is expected to grow at a CAGR of 20.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Bacteriophage Industry Forecast” looks at past sales and reviews total world Bacteriophage sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophage sales for 2023 through 2029. With Bacteriophage sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophage industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bacteriophage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophage market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophage and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophage.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophage market by product type, application, key players and key regions and countries.
Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
The global Bacteriophage market size is projected to grow from US$ 51.2 million in 2024 to US$ 153 million in 2030; it is expected to grow at a CAGR of 20.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Bacteriophage Industry Forecast” looks at past sales and reviews total world Bacteriophage sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophage sales for 2023 through 2029. With Bacteriophage sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophage industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bacteriophage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophage market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophage and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophage.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophage market by product type, application, key players and key regions and countries.
Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacteriophage Market Size 2019-2030
2.1.2 Bacteriophage Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Bacteriophage by Country/Region, 2019, 2023 & 2030
2.2 Bacteriophage Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 SsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Bacteriophage Market Size by Type
2.3.1 Bacteriophage Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bacteriophage Market Size Market Share by Type (2019-2024)
2.4 Bacteriophage Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Bacteriophage Market Size by Application
2.5.1 Bacteriophage Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bacteriophage Market Size Market Share by Application (2019-2024)
3 Bacteriophage Market Size by Player
3.1 Bacteriophage Market Size Market Share by Player
3.1.1 Global Bacteriophage Revenue by Player (2019-2024)
3.1.2 Global Bacteriophage Revenue Market Share by Player (2019-2024)
3.2 Global Bacteriophage Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bacteriophage by Region
4.1 Bacteriophage Market Size by Region (2019-2024)
4.2 Global Bacteriophage Annual Revenue by Country/Region (2019-2024)
4.3 Americas Bacteriophage Market Size Growth (2019-2024)
4.4 APAC Bacteriophage Market Size Growth (2019-2024)
4.5 Europe Bacteriophage Market Size Growth (2019-2024)
4.6 Middle East & Africa Bacteriophage Market Size Growth (2019-2024)
5 Americas
5.1 Americas Bacteriophage Market Size by Country (2019-2024)
5.2 Americas Bacteriophage Market Size by Type (2019-2024)
5.3 Americas Bacteriophage Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophage Market Size by Region (2019-2024)
6.2 APAC Bacteriophage Market Size by Type (2019-2024)
6.3 APAC Bacteriophage Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bacteriophage Market Size by Country (2019-2024)
7.2 Europe Bacteriophage Market Size by Type (2019-2024)
7.3 Europe Bacteriophage Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacteriophage by Region (2019-2024)
8.2 Middle East & Africa Bacteriophage Market Size by Type (2019-2024)
8.3 Middle East & Africa Bacteriophage Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bacteriophage Market Forecast
10.1 Global Bacteriophage Forecast by Region (2025-2030)
10.1.1 Global Bacteriophage Forecast by Region (2025-2030)
10.1.2 Americas Bacteriophage Forecast
10.1.3 APAC Bacteriophage Forecast
10.1.4 Europe Bacteriophage Forecast
10.1.5 Middle East & Africa Bacteriophage Forecast
10.2 Americas Bacteriophage Forecast by Country (2025-2030)
10.2.1 United States Market Bacteriophage Forecast
10.2.2 Canada Market Bacteriophage Forecast
10.2.3 Mexico Market Bacteriophage Forecast
10.2.4 Brazil Market Bacteriophage Forecast
10.3 APAC Bacteriophage Forecast by Region (2025-2030)
10.3.1 China Bacteriophage Market Forecast
10.3.2 Japan Market Bacteriophage Forecast
10.3.3 Korea Market Bacteriophage Forecast
10.3.4 Southeast Asia Market Bacteriophage Forecast
10.3.5 India Market Bacteriophage Forecast
10.3.6 Australia Market Bacteriophage Forecast
10.4 Europe Bacteriophage Forecast by Country (2025-2030)
10.4.1 Germany Market Bacteriophage Forecast
10.4.2 France Market Bacteriophage Forecast
10.4.3 UK Market Bacteriophage Forecast
10.4.4 Italy Market Bacteriophage Forecast
10.4.5 Russia Market Bacteriophage Forecast
10.5 Middle East & Africa Bacteriophage Forecast by Region (2025-2030)
10.5.1 Egypt Market Bacteriophage Forecast
10.5.2 South Africa Market Bacteriophage Forecast
10.5.3 Israel Market Bacteriophage Forecast
10.5.4 Turkey Market Bacteriophage Forecast
10.6 Global Bacteriophage Forecast by Type (2025-2030)
10.7 Global Bacteriophage Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Bacteriophage Forecast
11 Key Players Analysis
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Bacteriophage Product Offered
11.1.3 NPO Microgen Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Qingdao Phagepharm Bio-tech
11.2.1 Qingdao Phagepharm Bio-tech Company Information
11.2.2 Qingdao Phagepharm Bio-tech Bacteriophage Product Offered
11.2.3 Qingdao Phagepharm Bio-tech Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.2.5 Qingdao Phagepharm Bio-tech Latest Developments
11.3 Armata Pharmaceuticals, Inc.
11.3.1 Armata Pharmaceuticals, Inc. Company Information
11.3.2 Armata Pharmaceuticals, Inc. Bacteriophage Product Offered
11.3.3 Armata Pharmaceuticals, Inc. Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.3.5 Armata Pharmaceuticals, Inc. Latest Developments
11.4 Phaxiam Therapeutics
11.4.1 Phaxiam Therapeutics Company Information
11.4.2 Phaxiam Therapeutics Bacteriophage Product Offered
11.4.3 Phaxiam Therapeutics Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Phaxiam Therapeutics Main Business Overview
11.4.5 Phaxiam Therapeutics Latest Developments
11.5 Eliava BioPreparations
11.5.1 Eliava BioPreparations Company Information
11.5.2 Eliava BioPreparations Bacteriophage Product Offered
11.5.3 Eliava BioPreparations Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eliava BioPreparations Main Business Overview
11.5.5 Eliava BioPreparations Latest Developments
11.6 Intralytix
11.6.1 Intralytix Company Information
11.6.2 Intralytix Bacteriophage Product Offered
11.6.3 Intralytix Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Intralytix Main Business Overview
11.6.5 Intralytix Latest Developments
11.7 MicroMir
11.7.1 MicroMir Company Information
11.7.2 MicroMir Bacteriophage Product Offered
11.7.3 MicroMir Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MicroMir Main Business Overview
11.7.5 MicroMir Latest Developments
11.8 Phagelux
11.8.1 Phagelux Company Information
11.8.2 Phagelux Bacteriophage Product Offered
11.8.3 Phagelux Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Phagelux Main Business Overview
11.8.5 Phagelux Latest Developments
11.9 Pharmex Group, LLC
11.9.1 Pharmex Group, LLC Company Information
11.9.2 Pharmex Group, LLC Bacteriophage Product Offered
11.9.3 Pharmex Group, LLC Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pharmex Group, LLC Main Business Overview
11.9.5 Pharmex Group, LLC Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Bacteriophage Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 ACD Pharma
11.11.1 ACD Pharma Company Information
11.11.2 ACD Pharma Bacteriophage Product Offered
11.11.3 ACD Pharma Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ACD Pharma Main Business Overview
11.11.5 ACD Pharma Latest Developments
11.12 Proteon Pharmaceuticals
11.12.1 Proteon Pharmaceuticals Company Information
11.12.2 Proteon Pharmaceuticals Bacteriophage Product Offered
11.12.3 Proteon Pharmaceuticals Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Proteon Pharmaceuticals Main Business Overview
11.12.5 Proteon Pharmaceuticals Latest Developments
11.13 Micreos
11.13.1 Micreos Company Information
11.13.2 Micreos Bacteriophage Product Offered
11.13.3 Micreos Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Micreos Main Business Overview
11.13.5 Micreos Latest Developments
11.14 Locus Biosciences, Inc
11.14.1 Locus Biosciences, Inc Company Information
11.14.2 Locus Biosciences, Inc Bacteriophage Product Offered
11.14.3 Locus Biosciences, Inc Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Locus Biosciences, Inc Main Business Overview
11.14.5 Locus Biosciences, Inc Latest Developments
11.15 NexaBiome Limited
11.15.1 NexaBiome Limited Company Information
11.15.2 NexaBiome Limited Bacteriophage Product Offered
11.15.3 NexaBiome Limited Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 NexaBiome Limited Main Business Overview
11.15.5 NexaBiome Limited Latest Developments
11.16 PhagePro
11.16.1 PhagePro Company Information
11.16.2 PhagePro Bacteriophage Product Offered
11.16.3 PhagePro Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 PhagePro Main Business Overview
11.16.5 PhagePro Latest Developments
11.17 BiomX
11.17.1 BiomX Company Information
11.17.2 BiomX Bacteriophage Product Offered
11.17.3 BiomX Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 BiomX Main Business Overview
11.17.5 BiomX Latest Developments
11.18 INtODEWORLD, Inc.
11.18.1 INtODEWORLD, Inc. Company Information
11.18.2 INtODEWORLD, Inc. Bacteriophage Product Offered
11.18.3 INtODEWORLD, Inc. Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 INtODEWORLD, Inc. Main Business Overview
11.18.5 INtODEWORLD, Inc. Latest Developments
11.19 TechnoPhage
11.19.1 TechnoPhage Company Information
11.19.2 TechnoPhage Bacteriophage Product Offered
11.19.3 TechnoPhage Bacteriophage Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 TechnoPhage Main Business Overview
11.19.5 TechnoPhage Latest Developments
12 Research Findings and Conclusion